Evidence map›Paper›PMID 27803154›Full record

ArticleEndocrine connections2016

Effect of vitamin D supplementation on health status in non-vitamin D deficient people with type 2 diabetes mellitus.

S Westra, Y H M Krul-Poel, H J van Wijland, M M Ter Wee, F Stam, P Lips, F Pouwer, S Simsek

Open access · goldAbstract read
In one paragraph

Article in Endocrine connections, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Is there an association between serum 25(OH)DHormones (Athens, Greece) · 2020
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

S WestraDepartment of Internal MedicineMedical Centre Alkmaar, Alkmaar, the Netherlands.
Y H M Krul-PoelDepartment of Internal MedicineMedical Centre Alkmaar, Alkmaar, the Netherlands.
H J van WijlandDepartment of General PracticeDIAZON, Alkmaar, the Netherlands.
M M Ter WeeDepartment of Epidemiology and BiostatisticsVU Medical Centre, Amsterdam, the Netherlands.
F StamDepartment of Internal MedicineMedical Centre Alkmaar, Alkmaar, the Netherlands.
P LipsDepartment of Internal MedicineEndocrine Section, VU Medical Centre, Amsterdam, the Netherlands.
F PouwerDepartment of Medical and Clinical PsychologyTilburg University, Tilburg, the Netherlands.
S SimsekDepartment of Internal MedicineMedical Centre Alkmaar, Alkmaar, the Netherlands s.simsek@mca.nl.
Medisch Centrum Alkmaar · NLAmsterdam UMC Location VUmc · NLTilburg University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIncreased levels of depressive symptoms, fatigue or pain (all dimensions of reduced health-related quality of life (HRQOL)) are common in people with type 2 diabetes mellitus (DM). Earlier studies have reported associations between low vitamin D status and fatigue and depressive symptoms. The aim of the present study was to examine the effects of vitamin D supplementation on dimensions of HRQOL in people with type 2 DM.

designRandomised, double-blind, placebo-controlled trial.

methodsThe effect of monthly cholecalciferol 50,000 IU vs placebo on HRQOL was assessed in 275 adults with type 2 DM derived from general practices. HRQOL at baseline and after six months using the Short Form 36 Health Survey (SF-36) was collected. Linear regression analyses were used to compare the change in HRQOL over time between the vitamin D and placebo group.

results187/275 (68%) completed baseline and follow-up SF-36 and were included in the analysis. Median serum 25-hydroxyvitamin D almost doubled in the intervention group compared to that in the placebo group (58.5-106.0 nmol/L vs 60.0-61.5 nmol/L, respectively). A small significant difference (adjusted B: -8.90; 95% CI: -17.16 to -0.65) between both groups was seen concerning the SF-36 domain role limitations due to physical problems in disadvantage of the vitamin D group.

conclusionsSix months of vitamin D supplementation did not improve HRQOL in non-vitamin D-deficient people with type 2 DM managed on oral antidiabetic therapy.

Indexed as

health-related quality of lifeRCTtype 2 diabetes mellitusvitamin D

Identifiers

PMID27803154
PMCPMC5118972
OpenAlexW2549017885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.